GALWAY, IRELAND--April 27, 2016--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Danish pharmaceutical company Novo Nordisk AS (NYSE:NVO) (Bagsvaerd, Denmark) has announced plans to pump more than 100 million euro ($112.5 million) into new production facilities at its complex in Chartres, France. Within this article: Outlines spending plans in France, Denmark and the U.S.

Login to Read More